Our data demonstrate that NF-κB inhibition can block the acidic bile-induced overexpression of TNF-α, NF-κB transcriptional factor RELA(p65), and cancer related cytokines, IL-1β and IL-6. The gene discussed is NFKB1; the disease is cancer.